"Interleukin-5" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cytokine that promotes differentiation and activation of EOSINOPHILS. It also triggers activated B-LYMPHOCYTES to differentiate into IMMUNOGLOBULIN-secreting cells.
| Descriptor ID |
D015848
|
| MeSH Number(s) |
D12.644.276.374.465.202 D12.776.467.374.465.186 D23.529.374.465.202
|
| Concept/Terms |
Interleukin-5- Interleukin-5
- Interleukin 5
- BCGF-II
- Differentiation Factor, Eosinophil
- T-Cell-Replacing Factor
- T Cell Replacing Factor
- IL-5
- IL5
- T-Cell Replacing Factor
- Replacing Factor, T-Cell
- B-Cell Growth Factor-II
- B Cell Growth Factor II
- Eosinophil Differentiation Factor
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-5".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-5".
This graph shows the total number of publications written about "Interleukin-5" by people in this website by year, and whether "Interleukin-5" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1996 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 2 | 2 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 0 | 1 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2011 | 0 | 2 | 2 |
| 2017 | 1 | 2 | 3 |
| 2019 | 0 | 2 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interleukin-5" by people in Profiles.
-
IL-33-mediated Eosinophilia Protects against Acute Lung Injury. Am J Respir Cell Mol Biol. 2021 05; 64(5):569-578.
-
Transcriptional Atlas of Intestinal Immune Cells Reveals that Neuropeptide a-CGRP Modulates Group 2 Innate Lymphoid Cell Responses. Immunity. 2019 10 15; 51(4):696-708.e9.
-
Protection against Staphylococcus aureus bacteremia-induced mortality depends on ILC2s and eosinophils. JCI Insight. 2019 03 21; 4(6).
-
Pharmacokinetic drug evaluation of mepolizumab for the treatment of severe asthma associated with persistent eosinophilic inflammation in adults. Expert Opin Drug Metab Toxicol. 2017 Dec; 13(12):1275-1280.
-
ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s. Mucosal Immunol. 2018 01; 11(1):61-70.
-
Monoclonal Antibodies for the Treatment of Nasal Polyps. Immunol Allergy Clin North Am. 2017 05; 37(2):357-367.
-
Does cytokine profiling of aspirate from jaw cysts and tumors have a role in diagnosis? J Oral Maxillofac Surg. 2012 May; 70(5):1070-80.
-
Role of Rho kinase isoforms in murine allergic airway responses. Eur Respir J. 2011 Oct; 38(4):841-50.
-
CD43 regulates Th2 differentiation and inflammation. J Immunol. 2008 Jun 01; 180(11):7385-93.
-
Attenuated translocation of group IVa phospholipase A2 and up-regulated annexin-1 synthesis by glucocorticoid blocks beta 2-integrin adhesion in neutrophils. J Leukoc Biol. 2008 Feb; 83(2):344-51.